Persistent concerns that Alphabet Inc. has fallen behind in the artificial intelligence supremacy race has weighed on the ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Alphabet's forward P/E is historically low and 28.11% below Nasdaq's, making it an attractive buy at current levels. Click ...

Alphabet's on Wednesday unveiled its seventh-generation artificial intelligence chip named Ironwood, which the company said ...

NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...